Browse 1,116 High Blood Pressure clinical trials enrolling across the United States and Canada. 95 people applied to High Blood Pressure studies last month. Search by city or state to find one near you.
High blood pressure, also called hypertension, is a common condition in which the force of blood against artery walls is consistently too high, increasing the risk of heart attack, stroke, and other complications.
Clinical trials for high blood pressure evaluate therapies to better control blood pressure and reduce cardiovascular risk, giving participants access to advanced treatments.
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
for
Non Small Cell Lung Cancer,
Location: Boston MA, Austin, TX 78758 TX, San Antonio TX
Sponsor: Zumutor Biologics Inc.
Sex: All
Age: 18+
Code: NCT06451497
Phase1, Recruiting
Comparison of Two SpO2 Targets With Two Different Oximeters - Impact on FiO2 During Nasal High Flow Oxygen Therapy
for
Oxygen Delivery, Acute Respiratory Failure,
Location: Quebec
Sponsor: Laval University
Sex: All
Age: 18+
Code: NCT07168213
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
for
Melanoma, Non-small Cell Lung Cancer,
Location: Fairfax VA, Pittsburgh PA, Grand Rapids MI, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07115043
Phase1, Phase2, Recruiting
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06784726
Phase2, Recruiting
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06905509
Phase2, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Houston TX
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase1, Phase2, Recruiting
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: New York NY, Columbus OH, Grand Rapids MI,
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.